Could This Be the End of Cancer?

December 15, 2011

Newsweek Magazine

In an article marking the 40th anniversary of President Nixon's declaration of war on cancer, Newsweek and The Daily Beast examine the recent successes in cancer vaccines, a field which has, until recently, been plagued by false starts and failed studies. "If they succeed, cancer vaccines would revolutionize treatment. They could spell the end of chemotherapy and radiation, which can have horrific side effects, which tumor cells often become resistant to, and which often make so little difference" in extending survival, the magazine writes. "And they could make cancer as preventable, with a few jabs, as measles." A recent acceleration of progress with these vaccines is bringing new hope. In 2010, the U.S. Food and Drug Administration approved the first-ever tumor vaccine, called Provenge, to treat prostate cancer. Over the summer, the magazine noted, researchers at the University of Pennsylvania's Abramson Cancer Center unveiled what they call a cancer “breakthrough 20 years in the making”: a vaccine against chronic lymphocytic leukemia (CLL) that has brought about remissions of up to a year and counting—and which its inventors believe can be tweaked to attack lung cancer, ovarian cancer, myeloma, and melanoma... Read More

Read original press release about the CLL vaccine